SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15772888
Source:
http://linkedlifedata.com/resource/pubmed/id/15772888
Search
Subject
(
51
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007634
,
umls-concept:C0012764
,
umls-concept:C0017296
,
umls-concept:C0041703
pubmed:issue
3
pubmed:dateCreated
2005-3-17
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100883655
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin
,
http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates
,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Phthalazines
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines
,
http://linkedlifedata.com/resource/pubmed/chemical/ST 1481
,
http://linkedlifedata.com/resource/pubmed/chemical/imatinib
,
http://linkedlifedata.com/resource/pubmed/chemical/vatalanib
,
http://linkedlifedata.com/resource/pubmed/chemical/zoledronic acid
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1369-7056
pubmed:author
pubmed-author:SalmonsBrianB
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
203-5
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15772888-Antineoplastic Agents
,
pubmed-meshheading:15772888-Camptothecin
,
pubmed-meshheading:15772888-Clinical Trials, Phase II as Topic
,
pubmed-meshheading:15772888-Clinical Trials, Phase III as Topic
,
pubmed-meshheading:15772888-Diphosphonates
,
pubmed-meshheading:15772888-Entrepreneurship
,
pubmed-meshheading:15772888-Gene Therapy
,
pubmed-meshheading:15772888-Humans
,
pubmed-meshheading:15772888-Imidazoles
,
pubmed-meshheading:15772888-Molecular Structure
,
pubmed-meshheading:15772888-Phthalazines
,
pubmed-meshheading:15772888-Piperazines
,
pubmed-meshheading:15772888-Pyridines
,
pubmed-meshheading:15772888-Pyrimidines
,
pubmed-meshheading:15772888-Tissue Therapy
pubmed:year
2005
pubmed:articleTitle
Phacilitate Cell and Gene Therapy Forum 2005. Cell and gene therapy: a corporate perspective. 24-26 January 2005, Washington, DC, USA.
pubmed:affiliation
Austrianova Biotechnology GmbH, Veterinaerplatz 1, A-1210 Vienna, Austria. salmons@austrianova.com
pubmed:publicationType
Congresses